Literature DB >> 28593474

High Throughput Prediction Approach for Monoclonal Antibody Aggregation at High Concentration.

Mitja Zidar1, Ana Šušterič2, Miha Ravnik1,3, Drago Kuzman4.   

Abstract

PURPOSE: Characterization of the monoclonal antibody aggregation process and identification of stability factors that could be used as indicators of aggregation propensity with an emphasis on a large number of samples and low protein material consumption.
METHODS: Differential scanning calorimetry, dynamic light scattering and size exclusion chromatography were used as the main methodological approaches. Conformational stability, colloidal stability and aggregation kinetics were assessed for two different IgG monoclonal antibody (mAbs) subclasses. Aggregation was induced by exposing the mAbs to 55°C for 3 weeks. mAb samples were prepared in different formulations and concentrations from 1 mg/mL to 50 mg/mL.
RESULTS: High temperature stress of mAb samples revealed that monoclonal antibodies followed first order aggregation kinetics, which suggests that the rate-limiting step of monomer loss was unimolecular. Conformational stability of mAbs was estimated with denaturation temperature measurements. Colloidal stability was assessed with dynamic interaction parameter k D . The correlation between aggregation kinetics and colloidal and conformational stability factors was evaluated and the dynamic interaction parameter was found to be a promising predictor of aggregation propensity of monoclonal antibodies. The meaning of using an intermolecular interaction parameter for prediction of what is essentially a unimolecular process is also discussed.
CONCLUSIONS: This work estimates the significance of different predictors of aggregation propensity at high concentrations as a part of a high throughput, low resource screening method and is a contribution towards determining protein aggregation phenomena in actual systems used for the development and production of biopharmaceuticals.

Entities:  

Keywords:  aggregation modelling; aggregation predictors; biopharmaceuticals; intermolecular interactions; protein aggregation

Mesh:

Substances:

Year:  2017        PMID: 28593474     DOI: 10.1007/s11095-017-2191-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  38 in total

1.  Monoclonal Antibodies Follow Distinct Aggregation Pathways During Production-Relevant Acidic Incubation and Neutralization.

Authors:  Thomas Skamris; Xinsheng Tian; Matthias Thorolfsson; Hanne Sophie Karkov; Hanne B Rasmussen; Annette E Langkilde; Bente Vestergaard
Journal:  Pharm Res       Date:  2015-11-12       Impact factor: 4.200

Review 2.  Potent antibody therapeutics by design.

Authors:  Paul J Carter
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

Review 3.  The Zyggregator method for predicting protein aggregation propensities.

Authors:  Gian Gaetano Tartaglia; Michele Vendruscolo
Journal:  Chem Soc Rev       Date:  2008-05-27       Impact factor: 54.564

4.  Contrasting the Influence of Cationic Amino Acids on the Viscosity and Stability of a Highly Concentrated Monoclonal Antibody.

Authors:  Barton J Dear; Jessica J Hung; Thomas M Truskett; Keith P Johnston
Journal:  Pharm Res       Date:  2016-11-11       Impact factor: 4.200

5.  Dynamic light scattering application to study protein interactions in electrolyte solutions.

Authors:  Shaoxin Li; Da Xing; Junfeng Li
Journal:  J Biol Phys       Date:  2004-01       Impact factor: 1.365

6.  Statistics corner: A guide to appropriate use of correlation coefficient in medical research.

Authors:  M M Mukaka
Journal:  Malawi Med J       Date:  2012-09       Impact factor: 0.875

7.  The role of electrostatics in protein-protein interactions of a monoclonal antibody.

Authors:  D Roberts; R Keeling; M Tracka; C F van der Walle; S Uddin; J Warwicker; R Curtis
Journal:  Mol Pharm       Date:  2014-06-18       Impact factor: 4.939

8.  Concentration-dependent changes in apparent diffusion coefficients as indicator for colloidal stability of protein solutions.

Authors:  Katharina Christin Bauer; Mathias Göbel; Marie-Luise Schwab; Marie-Therese Schermeyer; Jürgen Hubbuch
Journal:  Int J Pharm       Date:  2016-07-12       Impact factor: 5.875

9.  Significance of unfolding thermodynamics for predicting aggregation kinetics: a case study on high concentration solutions of a multi-domain protein.

Authors:  Atul Saluja; Vikram Sadineni; Amol Mungikar; Vishal Nashine; Andrew Kroetsch; Charles Dahlheim; Venkatramana M Rao
Journal:  Pharm Res       Date:  2014-01-08       Impact factor: 4.200

10.  Identifying protein aggregation mechanisms and quantifying aggregation rates from combined monomer depletion and continuous scattering.

Authors:  Gregory V Barnett; Michael Drenski; Vladimir Razinkov; Wayne F Reed; Christopher J Roberts
Journal:  Anal Biochem       Date:  2016-08-07       Impact factor: 3.365

View more
  2 in total

1.  Phase-Appropriate Application of Analytical Methods to Monitor Subvisible Particles Across the Biotherapeutic Drug Product Life Cycle.

Authors:  Roman Mathaes; Linda Narhi; Andrea Hawe; Anja Matter; Karoline Bechtold-Peters; Sophia Kenrick; Sambit Kar; Olga Laskina; John Carpenter; Richard Cavicchi; Ellen Koepf; E Neil Lewis; Rukman De Silva; Dean Ripple
Journal:  AAPS J       Date:  2019-10-30       Impact factor: 4.009

Review 2.  Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods.

Authors:  Emily K Makowski; Lina Wu; Priyanka Gupta; Peter M Tessier
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.